SIGA Technologies (SIGA) Competitors $6.48 +0.21 (+3.35%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SIGA vs. FLXN, EBS, ORGO, NLTX, TARS, ARVN, GLPG, XNCR, IMCR, and RXRXShould you be buying SIGA Technologies stock or one of its competitors? The main competitors of SIGA Technologies include Flexion Therapeutics (FLXN), Emergent BioSolutions (EBS), Organogenesis (ORGO), Neoleukin Therapeutics (NLTX), Tarsus Pharmaceuticals (TARS), Arvinas (ARVN), Galapagos (GLPG), Xencor (XNCR), Immunocore (IMCR), and Recursion Pharmaceuticals (RXRX). These companies are all part of the "medical" sector. SIGA Technologies vs. Flexion Therapeutics Emergent BioSolutions Organogenesis Neoleukin Therapeutics Tarsus Pharmaceuticals Arvinas Galapagos Xencor Immunocore Recursion Pharmaceuticals SIGA Technologies (NASDAQ:SIGA) and Flexion Therapeutics (NASDAQ:FLXN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, community ranking, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends. Does the MarketBeat Community believe in SIGA or FLXN? Flexion Therapeutics received 567 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 63.34% of users gave Flexion Therapeutics an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote. CompanyUnderperformOutperformSIGA TechnologiesOutperform Votes523.81% Underperform Votes1676.19% Flexion TherapeuticsOutperform Votes57263.34% Underperform Votes33136.66% Do institutionals and insiders hold more shares of SIGA or FLXN? 55.4% of SIGA Technologies shares are held by institutional investors. Comparatively, 90.0% of Flexion Therapeutics shares are held by institutional investors. 1.5% of SIGA Technologies shares are held by company insiders. Comparatively, 9.1% of Flexion Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is SIGA or FLXN more profitable? SIGA Technologies has a net margin of 49.33% compared to Flexion Therapeutics' net margin of -100.32%. SIGA Technologies' return on equity of 49.06% beat Flexion Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets SIGA Technologies49.33% 49.06% 38.72% Flexion Therapeutics -100.32%N/A -44.26% Which has preferable valuation and earnings, SIGA or FLXN? SIGA Technologies has higher revenue and earnings than Flexion Therapeutics. Flexion Therapeutics is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSIGA Technologies$139.92M3.31$68.07M$1.205.40Flexion Therapeutics$85.55M5.36-$113.71M-$2.01-4.54 Does the media favor SIGA or FLXN? In the previous week, SIGA Technologies had 8 more articles in the media than Flexion Therapeutics. MarketBeat recorded 8 mentions for SIGA Technologies and 0 mentions for Flexion Therapeutics. SIGA Technologies' average media sentiment score of 0.72 beat Flexion Therapeutics' score of 0.00 indicating that SIGA Technologies is being referred to more favorably in the media. Company Overall Sentiment SIGA Technologies Positive Flexion Therapeutics Neutral Which has more volatility & risk, SIGA or FLXN? SIGA Technologies has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Flexion Therapeutics has a beta of 1.53, indicating that its stock price is 53% more volatile than the S&P 500. SummarySIGA Technologies beats Flexion Therapeutics on 9 of the 15 factors compared between the two stocks. Ad True Gold RepublicFed Declares War on AmericansFed Declares War on Americans Protect your wealth in the coming months… [RUSH MY FREE GUIDE NOW] Get SIGA Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIGA vs. The Competition Export to ExcelMetricSIGA TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$462.67M$6.61B$5.21B$8.86BDividend YieldN/A8.14%5.53%4.08%P/E Ratio5.405.5573.0914.32Price / Sales3.31357.131,249.4687.32Price / Cash6.5053.8240.9036.92Price / Book2.7310.617.196.54Net Income$68.07M$153.27M$119.54M$226.22M7 Day Performance9.09%3.98%2.10%3.77%1 Month Performance-1.97%-6.71%-2.43%4.64%1 Year Performance21.35%33.26%33.97%29.21% SIGA Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIGASIGA Technologies2.9653 of 5 stars$6.48+3.3%N/A+21.3%$462.67M$139.92M5.4040Analyst RevisionNews CoverageFLXNFlexion TherapeuticsN/A$9.12flatN/AN/A$458.93M$85.55M-4.54257EBSEmergent BioSolutions4.3258 of 5 stars$9.64+2.6%$14.00+45.2%+353.3%$522.30M$1.05B-2.301,600Analyst DowngradeORGOOrganogenesis4.2267 of 5 stars$4.11+2.2%$5.33+29.8%+56.4%$544.89M$455.04M-68.50950NLTXNeoleukin TherapeuticsN/A$15.59+1.7%N/A+46.3%$146.52MN/A-5.0190High Trading VolumeTARSTarsus Pharmaceuticals1.9476 of 5 stars$47.74+2.9%$54.20+13.5%+174.7%$1.83B$17.45M-12.1850ARVNArvinas3.0606 of 5 stars$26.13+4.1%$61.08+133.8%+20.8%$1.80B$78.50M-5.37445Analyst ForecastAnalyst RevisionNews CoverageGap UpGLPGGalapagos1.2745 of 5 stars$26.34+4.4%$30.75+16.7%-26.7%$1.74B$260.09M0.001,123Analyst DowngradeGap UpXNCRXencor3.4414 of 5 stars$24.090.0%$35.75+48.4%+33.5%$1.69B$85.16M-7.55280IMCRImmunocore2.8445 of 5 stars$33.24+3.5%$69.18+108.1%-29.3%$1.66B$249.43M-33.81497Positive NewsRXRXRecursion Pharmaceuticals2.0236 of 5 stars$5.79+0.7%$9.25+59.8%-15.9%$1.66B$44.58M-3.79400Analyst ForecastOptions Volume Related Companies and Tools Related Companies Flexion Therapeutics Alternatives Emergent BioSolutions Alternatives Organogenesis Alternatives Neoleukin Therapeutics Alternatives Tarsus Pharmaceuticals Alternatives Arvinas Alternatives Galapagos Alternatives Xencor Alternatives Immunocore Alternatives Recursion Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SIGA) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SIGA Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SIGA Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
